Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Glucose Dehydrogenase Market by Type (FAD-Glucose Dehydrogenase, PQQ-Glucose Dehydrogenase), By Application (Hospital, Clinic, Individual) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Glucose Dehydrogenase Market by Type (FAD-Glucose Dehydrogenase, PQQ-Glucose Dehydrogenase), By Application (Hospital, Clinic, Individual) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 144473 3300 Chemical & Material 377 241 Pages 4.6 (47)
                                          

The global glucose dehydrogenase market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The growth of this market is attributed to the increasing prevalence of diabetes and obesity in the world. The increasing number of people suffering from diabetes and obesity has led to an increase in demand for glucose dehydrogenase enzyme, which helps in breaking down sugar molecules into simpler forms that can be used by cells for energy production. The global glucose dehydrogenase market is segmented on the basis of type (FAGlucose Dehydrogenase, PQGlucose Dehydrogenase), application (hospital, clinic, individual) and region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa). North America accounted for a major share in terms of revenue generation due to high prevalence rates among diabetic patients as well as high adoption rates among hospitals.

  1. Glucose Dehydrogenase market growth is driven by the increasing prevalence of diabetes and obesity.
  2. Glucose Dehydrogenase market growth is also driven by the increasing demand for glucose-free food products, which are made possible with the use of glucose dehydrogenase enzymes.
  3. The increased use of glucose dehydrogenases in pharmaceuticals and cosmetics will also drive the market growth for this enzyme type over time.
  4. The increased research into new applications for this enzyme type will also drive the market growth for this enzyme type over time, as it has been found to be effective in breaking down cellulose and hemicelluloses, which can be used to produce biofuels or other chemicals that are currently derived from petroleum products such as oil or coal tar derivatives.

Industry Growth Insights published a new data on “Glucose Dehydrogenase Market”. The research report is titled “Glucose Dehydrogenase Market research by Types (FAD-Glucose Dehydrogenase, PQQ-Glucose Dehydrogenase), By Applications (Hospital, Clinic, Individual), By Players/Companies SEKISUI DIAGNOSTICS, Biokart, MedicRegister, Yuze Technology, Promega Corporation, EPS BIO”.

Scope Of The Report

Report Attributes

Report Details

Report Title

Glucose Dehydrogenase Market Research Report

By Type

FAD-Glucose Dehydrogenase, PQQ-Glucose Dehydrogenase

By Application

Hospital, Clinic, Individual

By Companies

SEKISUI DIAGNOSTICS, Biokart, MedicRegister, Yuze Technology, Promega Corporation, EPS BIO

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

241

Number of Tables & Figures

169

Customization Available

Yes, the report can be customized as per your need.


Global Glucose Dehydrogenase Industry Outlook


Global Glucose Dehydrogenase Market Report Segments:

The global Glucose Dehydrogenase market is segmented on the basis of:

Types

FAD-Glucose Dehydrogenase, PQQ-Glucose Dehydrogenase

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Hospital, Clinic, Individual

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. SEKISUI DIAGNOSTICS
  2. Biokart
  3. MedicRegister
  4. Yuze Technology
  5. Promega Corporation
  6. EPS BIO

Global Glucose Dehydrogenase Market Overview


Highlights of The Glucose Dehydrogenase Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. FAD-Glucose Dehydrogenase
    2. PQQ-Glucose Dehydrogenase
  1. By Application:

    1. Hospital
    2. Clinic
    3. Individual
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Glucose Dehydrogenase Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Glucose Dehydrogenase Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


Glucose dehydrogenase is an enzyme that catalyzes the conversion of glucose to water and hydrogen gas.

Some of the major players in the glucose dehydrogenase market are SEKISUI DIAGNOSTICS, Biokart, MedicRegister, Yuze Technology, Promega Corporation, EPS BIO.

The glucose dehydrogenase market is expected to register a CAGR of 5.5%.

                                            
1. Executive Summary

2. Assumptions and Acronyms Used

3. Research Methodology

4. Glucose Dehydrogenase Market Overview
   4.1. Introduction
      4.1.1. Market Taxonomy
      4.1.2. Market Definition
   4.2. Macro-Economic Factors
      4.2.1. Industry Outlook
   4.3. Glucose Dehydrogenase Market Dynamics
      4.3.1. Market Drivers
      4.3.2. Market Restraints
      4.3.3. Opportunity
      4.3.4. Market Trends
   4.4. Glucose Dehydrogenase Market - Supply Chain
   4.5. Global Glucose Dehydrogenase Market Forecast
      4.5.1. Glucose Dehydrogenase Market Size (US$ Mn) and Y-o-Y Growth
      4.5.2. Glucose Dehydrogenase Market Size (000’ Units) and Y-o-Y Growth
      4.5.3. Glucose Dehydrogenase Market Absolute $ Opportunity

5. Global Glucose Dehydrogenase Market Analysis and Forecast by Type
   5.1. Market Trends
   5.2. Introduction
      5.2.1. Basis Point Share (BPS) Analysis by Type
      5.2.2. Y-o-Y Growth Projections by Type
   5.3. Glucose Dehydrogenase Market Size and Volume Forecast by Type
      5.3.1. FAD-Glucose Dehydrogenase
      5.3.2. PQQ-Glucose Dehydrogenase
   5.4. Absolute $ Opportunity Assessment by Type
   5.5. Market Attractiveness/Growth Potential Analysis by Type

6. Global Glucose Dehydrogenase Market Analysis and Forecast by Application
   6.1. Market Trends
   6.2. Introduction
      6.2.1. Basis Point Share (BPS) Analysis by Application
      6.2.2. Y-o-Y Growth Projections by Application
   6.3. Glucose Dehydrogenase Market Size and Volume Forecast by Application
      6.3.1. Hospital
      6.3.2. Clinic
      6.3.3. Individual
   6.4. Absolute $ Opportunity Assessment by Application
   6.5. Market Attractiveness/Growth Potential Analysis by Application

7. Global Glucose Dehydrogenase Market Analysis and Forecast by Sales Channel
   7.1. Market Trends
   7.2. Introduction
      7.2.1. Basis Point Share (BPS) Analysis by Sales Channel 
      7.2.2. Y-o-Y Growth Projections by Sales Channel
   7.3. Glucose Dehydrogenase Market Size and Volume Forecast by Sales Channel 
      7.3.1. Manufacturer/Distributor/Service Provider
      7.3.2. Aftermarket
   7.4. Absolute $ Opportunity Assessment by Sales Channel
   7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel

8. Global Glucose Dehydrogenase Market Analysis and Forecast by Region
   8.1. Market Trends
   8.2. Introduction
      8.2.1. Basis Point Share (BPS) Analysis by Region
      8.2.2. Y-o-Y Growth Projections by Region
   8.3. Glucose Dehydrogenase Market Size and Volume Forecast by Region
      8.3.1. North America
      8.3.2. Latin America
      8.3.3. Europe
      8.3.4. Asia Pacific
      8.3.5. Middle East and Africa (MEA)
   8.4. Absolute $ Opportunity Assessment by Region
   8.5. Market Attractiveness/Growth Potential Analysis by Region
   8.6. Global Glucose Dehydrogenase Demand Share Forecast, 2019-2026

9. North America Glucose Dehydrogenase Market Analysis and Forecast
   9.1. Introduction
      9.1.1. Basis Point Share (BPS) Analysis by Country
      9.1.2. Y-o-Y Growth Projections by Country
   9.2. North America Glucose Dehydrogenase Market Size and Volume Forecast by Country
      9.2.1. U.S.
      9.2.2. Canada
   9.3. Absolute $ Opportunity Assessment by Country
   9.4. North America Glucose Dehydrogenase Market Size and Volume Forecast by Application
      9.4.1. Hospital
      9.4.2. Clinic
      9.4.3. Individual
   9.5. Basis Point Share (BPS) Analysis by Application
   9.6. Y-o-Y Growth Projections by Application
   9.7. North America Glucose Dehydrogenase Market Size and Volume Forecast by Type
      9.7.1. FAD-Glucose Dehydrogenase
      9.7.2. PQQ-Glucose Dehydrogenase
   9.8. Basis Point Share (BPS) Analysis by Type
   9.9. Y-o-Y Growth Projections by Type
   9.10. Market Attractiveness/Growth Potential Analysis
      9.10.1. By Country
      9.10.2. By Product Type
      9.10.3. By Application
      9.10.4. By Sales Channel
   9.11. North America Glucose Dehydrogenase Demand Share Forecast, 2019-2026

10. Latin America Glucose Dehydrogenase Market Analysis and Forecast
   10.1. Introduction
      10.1.1. Basis Point Share (BPS) Analysis by Country
      10.1.2. Y-o-Y Growth Projections by Country
      10.1.3. Latin America Average Pricing Analysis
   10.2. Latin America Glucose Dehydrogenase Market Size and Volume Forecast by Country
      10.2.1. Brazil
      10.2.2. Mexico
      10.2.3. Rest of Latin America
   10.3. Absolute $ Opportunity Assessment by Country
   10.4. Latin America Glucose Dehydrogenase Market Size and Volume Forecast by Application
      10.4.1. Hospital
      10.4.2. Clinic
      10.4.3. Individual
   10.5. Basis Point Share (BPS) Analysis by Application
   10.6. Y-o-Y Growth Projections by Application
   10.7. Latin America Glucose Dehydrogenase Market Size and Volume Forecast by Type
      10.7.1. FAD-Glucose Dehydrogenase
      10.7.2. PQQ-Glucose Dehydrogenase
   10.8. Basis Point Share (BPS) Analysis by Type
   10.9. Y-o-Y Growth Projections by Type
   10.10. Market Attractiveness/Growth Potential Analysis
      10.10.1. By Country
      10.10.2. By Product Type
      10.10.3. By Application
      10.10.4. By Sales Channel
   10.11. Latin America Glucose Dehydrogenase Demand Share Forecast, 2019-2026

11. Europe Glucose Dehydrogenase Market Analysis and Forecast
   11.1. Introduction
      11.1.1. Basis Point Share (BPS) Analysis by Country
      11.1.2. Y-o-Y Growth Projections by Country
      11.1.3. Europe Average Pricing Analysis
   11.2. Europe Glucose Dehydrogenase Market Size and Volume Forecast by Country
      11.2.1. Germany
      11.2.2. France
      11.2.3. Italy
      11.2.4. U.K.
      11.2.5. Spain
      11.2.6. Russia
      11.2.7. Rest of Europe
   11.3. Absolute $ Opportunity Assessment by Country
   11.4. Europe Glucose Dehydrogenase Market Size and Volume Forecast by Application
      11.4.1. Hospital
      11.4.2. Clinic
      11.4.3. Individual
   11.5. Basis Point Share (BPS) Analysis by Application
   11.6. Y-o-Y Growth Projections by Application
   11.7. Europe Glucose Dehydrogenase Market Size and Volume Forecast by Type
      11.7.1. FAD-Glucose Dehydrogenase
      11.7.2. PQQ-Glucose Dehydrogenase
   11.8. Basis Point Share (BPS) Analysis by Type
   11.9. Y-o-Y Growth Projections by Type
   11.10. Market Attractiveness/Growth Potential Analysis
      11.10.1. By Country
      11.10.2. By Product Type
      11.10.3. By Application
      11.10.4. By Sales Channel
   11.11. Europe Glucose Dehydrogenase Demand Share, 2019-2026

12. Asia Pacific Glucose Dehydrogenase Market Analysis and Forecast
   12.1. Introduction
      12.1.1. Basis Point Share (BPS) Analysis by Country
      12.1.2. Y-o-Y Growth Projections by Country
      12.1.3. Asia Pacific Average Pricing Analysis
   12.2. Asia Pacific Glucose Dehydrogenase Market Size and Volume Forecast by Country
      12.2.1. China
      12.2.2. Japan
      12.2.3. South Korea
      12.2.4. India
      12.2.5. Australia
      12.2.6. Rest of Asia Pacific (APAC)
   12.3. Absolute $ Opportunity Assessment by Country
   12.4. Asia Pacific Glucose Dehydrogenase Market Size and Volume Forecast by Application
      12.4.1. Hospital
      12.4.2. Clinic
      12.4.3. Individual
   12.5. Basis Point Share (BPS) Analysis by Application
   12.6. Y-o-Y Growth Projections by Application
   12.7. Asia Pacific Glucose Dehydrogenase Market Size and Volume Forecast by Type
      12.7.1. FAD-Glucose Dehydrogenase
      12.7.2. PQQ-Glucose Dehydrogenase
   12.8. Basis Point Share (BPS) Analysis by Type
   12.9. Y-o-Y Growth Projections by Type
   12.10. Market Attractiveness/Growth Potential Analysis
      12.10.1. By Country
      12.10.2. By Product Type
      12.10.3. By Application
      12.10.4. By Sales Channel
   12.11. Asia Pacific Glucose Dehydrogenase Demand Share, 2019-2026

13. Middle East & Africa Glucose Dehydrogenase Market Analysis and Forecast
   13.1. Introduction
      13.1.1. Basis Point Share (BPS) Analysis by Country
      13.1.2. Y-o-Y Growth Projections by Country
      13.1.3. Asia Pacific Average Pricing Analysis
   13.2. Middle East & Africa Glucose Dehydrogenase Market Size and Volume Forecast by Country
      13.2.1. Saudi Arabia
      13.2.2. South Africa
      13.2.3. UAE
      13.2.4. Rest of Middle East & Africa (MEA)
   13.3. Absolute $ Opportunity Assessment by Country
   13.4. Middle East & Africa Glucose Dehydrogenase Market Size and Volume Forecast by Application
      13.4.1. Hospital
      13.4.2. Clinic
      13.4.3. Individual
   13.5. Basis Point Share (BPS) Analysis by Application
   13.6. Y-o-Y Growth Projections by Application
   13.7. Middle East & Africa Glucose Dehydrogenase Market Size and Volume Forecast by Type
      13.7.1. FAD-Glucose Dehydrogenase
      13.7.2. PQQ-Glucose Dehydrogenase
   13.8. Basis Point Share (BPS) Analysis by Type
   13.9. Y-o-Y Growth Projections by Type
   13.10. Market Attractiveness/Growth Potential Analysis
      13.10.1. By Country
      13.10.2. By Product Type
      13.10.3. By Application
      13.10.4. By Sales Channel
   13.11. Middle East & Africa Glucose Dehydrogenase Demand Share, 2019-2026

14. Competition Landscape
   14.1. Global Glucose Dehydrogenase Market: Market Share Analysis
   14.2. Glucose Dehydrogenase Distributors and Customers
   14.3. Glucose Dehydrogenase Market: Competitive Dashboard
   14.4. Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.4.1. SEKISUI DIAGNOSTICS
         14.4.1.1. Overview
         14.4.1.2. Financials
         14.4.1.3. Developments
         14.4.1.4. Strategic Outlook
      14.4.2. Biokart
         14.4.2.1. Overview
         14.4.2.2. Financials
         14.4.2.3. Developments
         14.4.2.4. Strategic Outlook
      14.4.3. MedicRegister
         14.4.3.1. Overview
         14.4.3.2. Financials
         14.4.3.3. Developments
         14.4.3.4. Strategic Outlook
      14.4.4. Yuze Technology
         14.4.4.1. Overview
         14.4.4.2. Financials
         14.4.4.3. Developments
         14.4.4.4. Strategic Outlook
      14.4.5. Promega Corporation
         14.4.5.1. Overview
         14.4.5.2. Financials
         14.4.5.3. Developments
         14.4.5.4. Strategic Outlook
      14.4.6. EPS BIO
         14.4.6.1. Overview
         14.4.6.2. Financials
         14.4.6.3. Developments
         14.4.6.4. Strategic Outlook
      14.4.7. COMPANY7
         14.4.7.1. Overview
         14.4.7.2. Financials
         14.4.7.3. Developments
         14.4.7.4. Strategic Outlook
      14.4.8. COMPANY8
         14.4.8.1. Overview
         14.4.8.2. Financials
         14.4.8.3. Developments
         14.4.8.4. Strategic Outlook
      14.4.9. COMPANY9
         14.4.9.1. Overview
         14.4.9.2. Financials
         14.4.9.3. Developments
         14.4.9.4. Strategic Outlook
      14.4.10. COMPANY 10
         14.4.10.1. Overview
         14.4.10.2. Financials
         14.4.10.3. Developments
         14.4.10.4. Strategic Outlook
      14.4.11. COMPANY 11
         14.4.11.1. Overview
         14.4.11.2. Financials
         14.4.11.3. Developments
         14.4.11.4. Strategic Outlook
      14.4.12. COMPANY 12
         14.4.12.1. Overview
         14.4.12.2. Financials
         14.4.12.3. Developments
         14.4.12.4. Strategic Outlook
      14.4.13. COMPANY 13
         14.4.13.1. Overview
         14.4.13.2. Financials
         14.4.13.3. Developments
         14.4.13.4. Strategic Outlook
      14.4.14. COMPANY 14
         14.4.14.1. Overview
         14.4.14.2. Financials
         14.4.14.3. Developments
         14.4.14.4. Strategic Outlook
      14.4.15. COMPANY 15
         14.4.15.1. Overview
         14.4.15.2. Financials
         14.4.15.3. Developments
         14.4.15.4. Strategic Outlook
      14.4.16. COMPANY 16
         14.4.16.1. Overview
         14.4.16.2. Financials
         14.4.16.3. Developments
         14.4.16.4. Strategic Outlook
      14.4.17. COMPANY 17
         14.4.17.1. Overview
         14.4.17.2. Financials
         14.4.17.3. Developments
         14.4.17.4. Strategic Outlook
      14.4.18. COMPANY 18
         14.4.18.1. Overview
         14.4.18.2. Financials
         14.4.18.3. Developments
         14.4.18.4. Strategic Outlook
      14.4.19. COMPANY 19
         14.4.19.1. Overview
         14.4.19.2. Financials
         14.4.19.3. Developments
         14.4.19.4. Strategic Outlook
      14.4.20. COMPANY 20
         14.4.20.1. Overview
         14.4.20.2. Financials
         14.4.20.3. Developments
         14.4.20.4. Strategic Outlook

Our Trusted Clients

Contact Us